Therefore, we hypothesized that the combined application of tRA with the ATM inhibitor might greatly inhibit the progression of melanoma by targeting the UV–ATM–SerRS–VEGFA signaling pathway to suppress tumor angiogenesis. Here, VEGFA is linked to melanoma.